Show simple item record

dc.date.accessioned2020-07-27T18:47:46Z
dc.date.available2020-07-27T18:47:46Z
dc.date.issued2020-07-16
dc.identifier.govdocPAHO/IMS/PHE/COVID-19/20-0040
dc.identifier.urihttps://iris.paho.org/handle/10665.2/52515
dc.description.abstractPAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects.en_US
dc.language.isoenen_US
dc.publisherPAHOen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 IGO*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/igo/*
dc.subjectCOVID-19en_US
dc.subjectCoronavirusen_US
dc.subjectPandemicsen_US
dc.subjectChlorine Dioxideen_US
dc.titlePAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020en_US
dc.typeProcedures, manuals, guidelinesen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
dc.description.notesThe information included in this note reflects the available evidence at the date of publication.en_US
paho.isfeatured0en_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.source.centercodeUS1.1en_US
paho.relation.languageVersion10665.2/52484en_US
paho.contributor.departmentEvidence and Intelligence for Action in Health (EIH)en_US
paho.iswhotranslationNoen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 IGO
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO